March 27, 2019
The Ministry of Health, Labor and Welfare (MHLW) on March 26 approved two Enbrel (etanercept) biosimilar products, which will be the second batch of follow-on biologics to hit the market of Pfizer’s major rheumatoid arthritis drug. The two products are:...read more